Company / Income Tax
IRONWOOD PHARMACEUTICALS INC Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$46.0M
FY2025
5-year range
-$327.8M / $83.5M
FY2021-FY2025
Trend
-40.5%
vs FY2024
Sector context
#28 of 204
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's income tax of $46M is higher than 86% of companies in the Health Care sector (FY2025). Improved from $83M to $46M over the past 2 years.
Based on SEC 10-K filings.
$46M in FY2025 with a 3-year CAGR of +157.8%. Top quartile in the Health Care sector.
Improved from $83M to $46M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +157.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 204This company $46.0M Sector average $118.7M
▼
-61.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +157.8%, indicating consistent growth.
- In FY2025, income tax decreased 40.5% year-over-year.
- Ranks #28 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.0M | -40.5% |
| FY2024 | $77.4M | -7.3% |
| FY2023 | $83.5M | +3009.5% |
| FY2022 | $2.7M | +100.8% |
| FY2021 | -$327.8M | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026